Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FHQVA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,018
Award facts
- Contract value 100% obligated
- $14,017.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,017.54 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Biktarvy 50-200-25 mg tablets in units of 30 tablets. This is a firm fixed price contract with an ultimate completion date of September 17, 2025, and represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal military and veteran healthcare systems through its extensive portfolio of pharmaceutical products and medical supplies. The company's relationship with DLA encompasses a comprehensive range of therapeutic categories including specialty medications, vaccines, and medical devices. This particular delivery order for Biktarvy, an antiretroviral medication, reflects the company's ongoing role in supplying essential pharmaceutical commodities to support military healthcare programs globally. The competitively awarded contract demonstrates AmerisourceBergen Drug Corp's capability to meet federal procurement requirements and support the Defense Health Agency and other government healthcare systems through flexible contract vehicles.
Quick answers
Who was awarded contract SPE2DB25FHQVA?
SPE2DB25FHQVA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FHQVA worth?
The government has obligated $14,018 on SPE2DB25FHQVA.
Is contract SPE2DB25FHQVA an order under another contract?
Yes. SPE2DB25FHQVA is a delivery order under SPE2DB24D2212, an indefinite delivery contract.
Was contract SPE2DB25FHQVA competed?
The extent of competition for SPE2DB25FHQVA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award